Health Policy Manag.  2024 Sep;34(3):238-248. 10.4332/KJHPA.2024.34.3.238.

A Study on Cooperation Strategies between the HongNeung Bio Cluster and Overseas Bio Clusters

• Jeon HS
• Jung KT

• KMID: 2562581
• DOI: http://doi.org/10.4332/KJHPA.2024.34.3.238

Abstract

The recent coronavirus disease 2019 pandemic has accelerated market growth by promoting opportunities and advancements in drug development and vaccine manufacturing. Despite the rapid expansion of the global bio market, South Korea’s bio market holds a relatively small share. To address this, the government is implementing various strategies, including the establishment of bio clusters, to foster innovation and growth in the bio industry. This study focuses on Korea’s HongNeung bio cluster and conducts a comparative analysis with the Boston Bio Cluster in the United States and the Biopolis in Singapore. By examining the development history, structure, and success factors of these clusters through three categories—infrastructure, internal components, and policies and systems—commonalities and differences among the clusters are analyzed. Subsequently, development strategies for the HongNeung bio cluster are proposed. For the HongNeung bio cluster to grow into a leading bio cluster, strong government support, expansion of innovative infrastructure, talent acquisition, and the implementation of customized policies such as strategic partnerships are necessary. Additionally, the establishment of active collaboration and exchange systems with overseas bio clusters is required.

Keyword

Technology commercialization; Seoul; Boston; Singapore